| Literature DB >> 35869098 |
Wajahat Rashid Mir1, Basharat Ahmad Bhat1, Muzafar Ahmad Rather2, Showkeen Muzamil2, Abdullah Almilaibary3, Mustfa Alkhanani4, Manzoor Ahmad Mir5.
Abstract
Geranium wallichianum D. Don ex Sweet is a well-known medicinal plant in Kashmir Himalya. The evidence for its modern medicinal applications remains majorly unexplored. The present study was undertaken to elucidate the detailed antimicrobial promises of different crude extracts (methanolic, ethanolic, petroleum ether, and ethyl acetate) of G. wallichainum against common human bacterial and fungal pathogens in order to scientifically validate its traditional use. The LC-MS analysis of G. wallichainum yielded 141 bioactive compounds with the vast majority of them having therapeutic applications. Determination of minimum inhibitory concentrations (MICs) by broth microdilution method of G. wallichainum was tested against bacterial and fungal pathogens with MICs ranging from 0.39 to 400 µg/mL. Furthermore, virtual ligands screening yielded elatine, kaempferol, and germacrene-A as medicinally most active constituents and the potential inhibitors of penicillin-binding protein (PBP), dihydropteroate synthase (DHPS), elongation factor-Tu (Eu-Tu), ABC transporter, 1,3 beta glycan, and beta-tubulin. The root mean square deviation (RMSD) graphs obtained through the molecular dynamic simulations (MDS) indicated the true bonding interactions which were further validated using root mean square fluctuation (RMSF) graphs which provided a better understanding of the amino acids present in the proteins responsible for the molecular motions and fluctuations. The effective binding of elatine, kaempferol, and germacrene-A with these proteins provides ground for further research to understand the underlying mechanism that ceases the growth of these microbes.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35869098 PMCID: PMC9307801 DOI: 10.1038/s41598-022-16102-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Details of the locations where plant samples of G. wallichianum were collected from four main sites in India's Jammu and Kashmir union region for ethnopharmacological investigation.
| Name of sampling site | Geographical coordinates | Sample collection date | Sample type | ||
|---|---|---|---|---|---|
| Latitude | Longitude | Altitude (amsl) | |||
| Sadhna Pass | 34.4016°N | 73.9535°E | 3000 | 23-07-20 | Whole plant |
| Kupwara | 34°31′33″N | 74°15′19″E | 3545 | 26-07-20 | Whole plant |
| Sinthantop | 33.5811°N | 75.5102°E | 3784 | 02-08-20 | Whole plant |
| Daksum (Anantnag) | 33.6114°N | 75.4359°E | 2438 | 09-08-20 | Whole plant |
| Uri (Baramullah) | 34.0881°N | 74.0340°E | 1579 | 04-08-20 | Whole plant |
Figure 13D structure of different microbial target proteins.
Results of preliminary tests of G. wallichianum.
| Tests | Inference | Methanol | Ethanol | Ethyl acetate | Petroleum ether |
|---|---|---|---|---|---|
| Molisch’s test | Violet ring | + | + | + | + |
| Fehling’s test | Formation of yellow pot | + | − | + | − |
| Benedict’s test | Red precipitate | + | + | + | + |
| Anthraquinone glycosides | The ammoniacal layer turns pink | − | + | + | + |
| Foam test | Persistent foam | + | + | + | + |
| Shinoda test | Pink color appears | + | + | + | + |
| Alkaline Reagent test | Concentrated yellow color | + | − | + | + |
| FeCl3 test | Black color | + | + | + | + |
| Lead acetate test | White precipitate | + | + | + | − |
| Salkowski reaction | Chloroform layer appears red | + | − | + | + |
| Mayer’s test | Formation of precipitate | − | − | + | + |
| Dragendroff’s test | Organic precipitate | + | + | + | + |
| Wagner’s test | Formation of radish brown precipitate | + | + | − | − |
| Terpenoid test | Grey color | + | + | + | + |
Figure 2LC–MS-ESI–MS chromatograms of reference compounds using Nexera in Methanolic extract.
The major components found in G. wallichianum based on LC–MS analysis.
| Compound name | IUPAC name | Molecular formula | Molecular weight (g/mol) |
|---|---|---|---|
| Kaempferol | 3,5,7-Trihydroxy-2-(4-hydroxyphenyl) chromen-4-one | C15H10O6 | 286.24 |
| Kaempferol-3-O-glucoside | 5,7-Dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl) oxan-2-yl] oxychromen-4-one | C21H20O11 | 448.4 |
| Quercetin-3-O rutinoside | 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-3-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl) oxymethyl] oxan-2-yl] oxychromen-4-one | C27H30O16 | 610.5 |
| Gallic acid | 3,4,5-Trihydroxybenzoic acid | C7H6O5 | 170.12 |
| Germacrene D | (1Z,6Z,8S)-1-methyl-5-methylidene-8-propan-2-ylcyclodeca-1,6-diene | C15H24 | 204.35 |
| Germacrene A | (1E,5E,8R)-1,5-dimethyl-8-prop-1-en-2-ylcyclodeca-1,5-diene | C15H24 | 204.35 |
| Elatine | [(4S,6S,19R,21R)-14-ethyl-4,6,19,21-tetramethoxy-9,11-dioxa-14 azaheptacyclo [10.7.2.12,5.01,13.03,8.08,12.016,20] docosan-16-yl] methyl 2-[(3S)-3-methyl-2,5-dioxopyrrolidin-1-yl] benzoate | C38H50N2O10 | 694.8 |
| Germacrone | (3E,7E)-3,7-dimethyl-10-propan-2-ylidenecyclodeca-3,7-dien-1-one | C15H22O | 218.33 |
| Quercetin | 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one | C15H10O7 | 302.23 |
| p- Coumaric acid | (2R)-6-methyl-2-[(1R)-4-methylcyclohex-3-en-1-yl] hept-5-en-2-ol | C15H26O | 222.37 |
| Alfa Bisabolol | (E)-3-(4-hydroxyphenyl) prop-2-enoic acid | C9H8O3 | 164.16 |
Figure 3Structures of the compounds identified based on LC–MS from G. wallichainum.
Invitro antimicrobial activity of different extracts of G. wallichianum.
| Strain | MIC (µg/mL)* | ||||
|---|---|---|---|---|---|
| ME | ET | EA | PE | CIP/AMF-B | |
| 100 | 50 | 100 | 100 | 0.625 | |
| 6.25 | 3.12 | 3.12 | 1.56 | 1.25 | |
| 6.25 | 25 | 25 | 25 | 0.039 | |
| 25 | 25 | 12.5 | 12.5 | 0.625 | |
| 25 | 25 | 6.25 | 25 | 1.25 | |
| 25 | 25 | 25 | 25 | 03.12 | |
| 200 | 6.25 | > 400 | > 400 | 1.25 | |
| > 400 | > 400 | > 400 | > 400 | 2 .5 | |
| > 400 | > 400 | > 400 | > 400 | 2 .5 | |
*Results are the average of the triplicate readings. Where CIP: Ciprofloxacin (Positive antibacterial agent), AMF-B: Amphotericin-B (Positive antifungal agent), PE: Petroleum Ether, ET: Ethanol, ME: Methanol, EA: Ethyl Acetate.
The binding affinity of selected compounds against microbial proteins.
| Ligands | Dihydropteroate synthase (kcal/mol) | Penicillin binding protein (kcal/mol) | Elongation factor EF-Tu (kcal/mol) |
|---|---|---|---|
| Kaempferol | − 8.0 | − 7.9 | − 6.1 |
| Germacrene A | − 7.2 | − 7.1 | − 6.2 |
| Elatine | − 8.5 | − 9.2 | − 8.2 |
Figure 4(a) 3D interactions of Ligands with (A) Dihydropteroate synthase (B) Elongation factor Tu and (C) Penicillin Binding Protein (D) ABC transporter (E) 1,3-Betaglycan (F) Beta-tubulin with Elatine and 2D structure of ligands interacted with respective amino acids. Read the text for further information. (b) 3D interactions of Ligands with (A) Dihydropteroate synthase (B) Elongation factor Tu and (C) Penicillin Binding Protein (D) ABC transporter (E) 1,3-Betaglycan (F) Beta-tubulin with Kaempherol and 2D structure of ligands interacted with respective amino acids. Read the text for further information. (c). 3D interactions of Ligands with (A) Dihydropteroate synthase (B) Elongation factor Tu and (C) Penicillin Binding Protein (D) ABC transporter (E) 1,3-Betaglycan (F) Beta-tubulin with Germacrene A and 2D structure of ligands interacted with respective amino acids. Read the text for further information.
Lists the interacting amino acid residues involved in the ligand–protein interaction of the selected compounds against six different targets and bond lengths between the amino acid of the target protein and ligand.
| Ligand | Target proteins | Bond lengths | Interacting amino acids |
|---|---|---|---|
| Kaempferol | Penicillin-binding protein (PBP) | 3.40, 2.02, 2.70, 1.94, 1.88, 2.53 | ILE-371, PHE-450, ASN-377, SER-337, LYS-340, ARG-372 and GLN-447 |
| Kaempferol | Elongation factor Tu (ETU) | 5.29, 2.29, 2.05, 2.89, 2.90, 2.14 | ASP-99, HIS-11, GLU-201, ASP-13, PRO-202, ARG-204 and LYS-208 |
| Kaempferol | Dihydropteroate synthase (DHPS) | 2.40, 2.13, 3.74, 4.10, 5.32, 4.55, 4.58 | ASP-269, ALA-270, LYS-19, SER-262, HIS-58 and GLU-18 |
| Kaempferol | ABC transporter | 5.47, 2.23, 5.05, 4.90, 5.48 | LEU-184, ILE-206, VAL-49, PHE-196 and LYS-188 |
| Kaempferol | 1,3 β-glycan | 2.58, 4.44, 5.28, 3.56, 4.66, 4.69, 5.50 | ASN-199, GLU-259, LYS-313, PHE-305, ASN-159 and ILE-200 |
| Kaempferol | Beta-tubulin | 3.64, 3.46, 2.17, 2.56, 4.44 | VAL-79, TRP-96, LEU-87 and ALA-93 |
| Germacrene A | Penicillin-binding protein (PBP) | 4.35, 4.75, 2.05 | LEU-302 and LYS-615 |
| Germacrene A | Dihydropteroate synthase (DHPS) | 4.77, 5.65, 4,19, 3.01 | MET-200, ARG-201 and LEU-197 |
| Germacrene A | Elongation factor Tu (ETU) | 3.70, 4.86, 0.58, 3.91 | PHE-218, ILE-220, VAL-226 and THR-228 |
| Germacrene A | ABC transporter | 2.04, 5.02, 4.54, 5.16, 5.84 | LEU-184, ILE-194, VAL-49, PHE-181 and GLN-185 |
| Germacrene A | 1,3 β-glycan, | 1.45, 2.35, 5.06, 4.33, 5.01 | PHE-205, ARG-123, ASP-208, GLU-118, TYR-159 and TYR-201 |
| Germacrene A | Beta-tubulin | 2.14, 5.30, 5.39, 1.44, 5.20, 1.91, 3.88 | VAL-79, LEU-87, TRP-96, ALA-93 and ILE-113 |
| Elatine | Penicillin-binding protein (PBP) | 1.80, 1.57, 2.05, 2.88, 3.58 | TRP-374, GLU-378, TYR-568, THR-566 and LEU-565 |
| Elatine | Elongation factor Tu (ETU) | 2.43, 2.79, 2.59, 3.46, 2.65, 1.95 | GLU-203, ASN-13, ARG-204, ALA-205, LYS-208, GLN-97 and GLY-371 |
| Elatine | Dihydropteroate synthase (DHPS) | 2.78, 3.33, 5.09, 3.17 | TYR-103, ASN-147, ILE-122, PHE-123, TRP-189, ILE-150, ARG-148 and ALA-190 |
| Elatine | ABC transporter | 3.32, 4.66, 2.39, 2.90, 2.14, 3.87 | LEU-42, ILE-219, ASN-41 and GLY-39 |
| Elatine | 1,3 β-glycan | 2.02, 2.04, 3.25, 3.30, 3.87, 4.99 | LEU-237, ARG-175, SER-160, THR-166, TYR-167, PRO-169 and ALA-236 |
| Elatine | Beta-tubulin | 3.54, 3.79, 3.38, 3.26, 5.35, 5.36 | SER-160, LEU-163, TYR-167, THR-166, PRO-169 and ALA-236 |
Figure 5Protein–ligand RMSD plot.
Figure 6Protein–RMSF plot.
Figure 7Hydrogen bond contact analysis of lead compound and elatine–protein complexes. Various intermolecular interactions made by elatine–protein amino acid residues with lead ligand during molecular dynamics simulations. Bar colors: Hydrogen bond (Green), Hydrophobic (Purple), Water bridge (Blue).
Figure 8A schematic of detailed ligand atom interactions with the protein residues. Interactions that occur more than 30.0% of the simulation time in the selected trajectory (0.00 through 100.00 nsec), are shown.